These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20919551)

  • 1. [Bizerine: new anticholinesterase drug with selective gastrointestinal action].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Shchemeleva NI
    Eksp Klin Farmakol; 2010 Aug; 73(8):14-6. PubMed ID: 20919551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs.
    Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K
    Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New data on the pharmacokinetics of aminostigmine].
    Prozorovskiĭ VB; Chepur SV; Vorob'ev-Desiatovskiĭ NV; Panov PB
    Eksp Klin Farmakol; 1998; 61(5):46-9. PubMed ID: 9854634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].
    Prozorovskiĭ VB; Velikova VD; Pshenkina NN; Vasilenko ET
    Eksp Klin Farmakol; 1996; 59(1):64-7. PubMed ID: 8704639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long-Lasting Enhancing Effect of Distigmine on Acetylcholine-Induced Contraction of Guinea Pig Detrusor Smooth Muscle Correlates with Its Anticholinesterase Activity.
    Obara K; Ogawa T; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(7):1092-1100. PubMed ID: 28674252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
    Prozorovskiĭ VB; Sazonova AV
    Eksp Klin Farmakol; 1995; 58(5):57-61. PubMed ID: 8704593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
    Prozorovskiĭ VB; Iudkina NI
    Anesteziol Reanimatol; 1991; (1):25-6. PubMed ID: 1862957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Kokushkina AV
    Vopr Med Khim; 1999; 45(6):525-9. PubMed ID: 10761219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
    Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
    Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of anticholinesterase activity and the effectiveness of anticholinesterase substances].
    Prozorovskĭ VB; Artem'ev VS; Tonkopiĭ VD; Konstorum MG
    Farmakol Toksikol; 1975; 38(4):402-6. PubMed ID: 1213123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pyridostigmine and syntostigmine pretreatment on the inhibition of acetylcholinesterases by o-pinacolyl-methylphosphonofluoridate. In vitro experiments with rat tissues.
    Patocka J
    Biomed Biochim Acta; 1989; 48(9):715-20. PubMed ID: 2619740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison between the hypertensive activity and anticholinesterase activity of neostigmine].
    Siro-Brigiani G; Chieppa D
    Arch Ital Sci Farmacol; 1965; 15(3):164-7. PubMed ID: 5877518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histamine blockers increase efficacy of specific antidote prophylaxis of intoxication by cholinesterase inhibitors in mice].
    Prozorovskiĭ VB; Skopichev VG; Ditiateva ZhA; Sazonova AV
    Eksp Klin Farmakol; 2000; 63(4):64-7. PubMed ID: 11022312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
    Roberts DV; Taylor K; Wilson A
    J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
    [No Abstract]   [Full Text] [Related]  

  • 19. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration.
    Grauer E; Alkalai D; Kapon J; Cohen G; Raveh L
    Toxicol Appl Pharmacol; 2000 May; 164(3):301-4. PubMed ID: 10799340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of neuromuscular blockade.
    Bevan DR; Donati F; Kopman AF
    Anesthesiology; 1992 Oct; 77(4):785-805. PubMed ID: 1416176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.